Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Change Financial Ltd ( (AU:CCA) ) just unveiled an announcement.
Change Financial reported a record revenue quarter for Q2 FY26, with revenue rising 34% year-on-year to US$4.7m and customer receipts reaching US$3.9m, while approximately 70% of year-to-date revenue came from recurring streams. The company delivered unaudited Underlying EBITDA of US$0.9m for the quarter and US$1.8m for the half, signalling an operating leverage inflection point, driven by growth in its Vertexon PaaS platform, which now supports more than 110,000 active revenue-generating cards, a 66% increase on the prior period. With new sales to both new and existing Vertexon and PaySim clients, including a new fintech client in the South Pacific and the onboarding of an embedded finance client expected to begin contributing in Q3 FY26, Change has upgraded its FY26 revenue and EBITDA expectations and ends the quarter with US$2.6m in cash and no debt, reinforcing its positioning for profitable growth in the second half of the financial year.
The most recent analyst rating on (AU:CCA) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on Change Financial Ltd stock, see the AU:CCA Stock Forecast page.
More about Change Financial Ltd
Change Financial Ltd is an ASX-listed payments technology company that provides card issuing and payments-as-a-service (PaaS) solutions, primarily through its Vertexon platform and PaySim product suite. The company focuses on embedded finance, fintechs and financial institutions, particularly in regions such as the South Pacific, enabling clients to issue and manage payment cards and related digital payment services at scale.
Average Trading Volume: 365,751
Technical Sentiment Signal: Buy
Current Market Cap: A$48.33M
See more data about CCA stock on TipRanks’ Stock Analysis page.

